Global Pediatric Drugs and Vaccines Market Research Report 2023(Status and Outlook)


Attention: There is an updated edition available for this report.

Global Pediatric Drugs and Vaccines Market Research Report 2023(Status and Outlook)



Report Overview

Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.

The Global Pediatric Drugs and Vaccines Market Size was estimated at USD 95480.00 million in 2022 and is projected to reach USD 174541.18 million by 2029, exhibiting a CAGR of 9.00% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Pediatric Drugs and Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pediatric Drugs and Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pediatric Drugs and Vaccines market in any manner.

Global Pediatric Drugs and Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck & Co., Inc. (USA)

Abbott Laboratories (USA)

Amgen, Inc. (USA)

Eli Lilly and Company (USA)

F. Hoffmann-La Roche Ltd (Switzerland)

Genentech, Inc. (USA)

GlaxoSmithKline plc. (UK)

Janssen Biologics B.V. (USA)

Actelion Pharmaceuticals

AstraZeneca Plc. (UK)

Boehringer Ingelheim GmbH (Germany)

Bristol-Myers Squibb Company (USA)

Allergan, Inc. (USA)

Novartis AG (Switzerland)

Novo Nordisk A/S (Denmark)

Pfizer, Inc. (USA)

Sanofi S.A (France)

Shionogi Inc. (USA)

Takeda

Market Segmentation (by Type)

Diphtheria

Influenza

Hepatitis

Pneumococcal Diseases

Meningococcal Diseases

Mumps

Others

Market Segmentation (by Application)

Cars, SUV and ATVs

Recreational Vehicle (RV)/Motorhomes

Vans/Pickup Truck

Boat Trailers

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Pediatric Drugs and Vaccines Market

Overview of the regional outlook of the Pediatric Drugs and Vaccines Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pediatric Drugs and Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pediatric Drugs and Vaccines
1.2 Key Market Segments
1.2.1 Pediatric Drugs and Vaccines Segment by Type
1.2.2 Pediatric Drugs and Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pediatric Drugs and Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Pediatric Drugs and Vaccines Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pediatric Drugs and Vaccines Market Competitive Landscape
3.1 Global Pediatric Drugs and Vaccines Sales by Manufacturers (2018-2023)
3.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.3 Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pediatric Drugs and Vaccines Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Pediatric Drugs and Vaccines Sales Sites, Area Served, Product Type
3.6 Pediatric Drugs and Vaccines Market Competitive Situation and Trends
3.6.1 Pediatric Drugs and Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pediatric Drugs and Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pediatric Drugs and Vaccines Industry Chain Analysis
4.1 Pediatric Drugs and Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pediatric Drugs and Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pediatric Drugs and Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2018-2023)
6.3 Global Pediatric Drugs and Vaccines Market Size Market Share by Type (2018-2023)
6.4 Global Pediatric Drugs and Vaccines Price by Type (2018-2023)
7 Pediatric Drugs and Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pediatric Drugs and Vaccines Market Sales by Application (2018-2023)
7.3 Global Pediatric Drugs and Vaccines Market Size (M USD) by Application (2018-2023)
7.4 Global Pediatric Drugs and Vaccines Sales Growth Rate by Application (2018-2023)
8 Pediatric Drugs and Vaccines Market Segmentation by Region
8.1 Global Pediatric Drugs and Vaccines Sales by Region
8.1.1 Global Pediatric Drugs and Vaccines Sales by Region
8.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Pediatric Drugs and Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pediatric Drugs and Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pediatric Drugs and Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck andamp; Co., Inc. (USA)
9.1.1 Merck andamp; Co., Inc. (USA) Pediatric Drugs and Vaccines Basic Information
9.1.2 Merck andamp; Co., Inc. (USA) Pediatric Drugs and Vaccines Product Overview
9.1.3 Merck andamp; Co., Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance
9.1.4 Merck andamp; Co., Inc. (USA) Business Overview
9.1.5 Merck andamp; Co., Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis
9.1.6 Merck andamp; Co., Inc. (USA) Recent Developments
9.2 Abbott Laboratories (USA)
9.2.1 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Basic Information
9.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Overview
9.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Market Performance
9.2.4 Abbott Laboratories (USA) Business Overview
9.2.5 Abbott Laboratories (USA) Pediatric Drugs and Vaccines SWOT Analysis
9.2.6 Abbott Laboratories (USA) Recent Developments
9.3 Amgen, Inc. (USA)
9.3.1 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Basic Information
9.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Overview
9.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance
9.3.4 Amgen, Inc. (USA) Business Overview
9.3.5 Amgen, Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis
9.3.6 Amgen, Inc. (USA) Recent Developments
9.4 Eli Lilly and Company (USA)
9.4.1 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Basic Information
9.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Overview
9.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Market Performance
9.4.4 Eli Lilly and Company (USA) Business Overview
9.4.5 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines SWOT Analysis
9.4.6 Eli Lilly and Company (USA) Recent Developments
9.5 F. Hoffmann-La Roche Ltd (Switzerland)
9.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Basic Information
9.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Overview
9.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Market Performance
9.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
9.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines SWOT Analysis
9.5.6 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments
9.6 Genentech, Inc. (USA)
9.6.1 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Basic Information
9.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Overview
9.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance
9.6.4 Genentech, Inc. (USA) Business Overview
9.6.5 Genentech, Inc. (USA) Recent Developments
9.7 GlaxoSmithKline plc. (UK)
9.7.1 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Basic Information
9.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Overview
9.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Market Performance
9.7.4 GlaxoSmithKline plc. (UK) Business Overview
9.7.5 GlaxoSmithKline plc. (UK) Recent Developments
9.8 Janssen Biologics B.V. (USA)
9.8.1 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Basic Information
9.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Overview
9.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Market Performance
9.8.4 Janssen Biologics B.V. (USA) Business Overview
9.8.5 Janssen Biologics B.V. (USA) Recent Developments
9.9 Actelion Pharmaceuticals
9.9.1 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Basic Information
9.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Overview
9.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Market Performance
9.9.4 Actelion Pharmaceuticals Business Overview
9.9.5 Actelion Pharmaceuticals Recent Developments
9.10 AstraZeneca Plc. (UK)
9.10.1 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Basic Information
9.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Overview
9.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Market Performance
9.10.4 AstraZeneca Plc. (UK) Business Overview
9.10.5 AstraZeneca Plc. (UK) Recent Developments
9.11 Boehringer Ingelheim GmbH (Germany)
9.11.1 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Basic Information
9.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Overview
9.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Market Performance
9.11.4 Boehringer Ingelheim GmbH (Germany) Business Overview
9.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments
9.12 Bristol-Myers Squibb Company (USA)
9.12.1 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Basic Information
9.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Overview
9.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Market Performance
9.12.4 Bristol-Myers Squibb Company (USA) Business Overview
9.12.5 Bristol-Myers Squibb Company (USA) Recent Developments
9.13 Allergan, Inc. (USA)
9.13.1 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Basic Information
9.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Overview
9.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance
9.13.4 Allergan, Inc. (USA) Business Overview
9.13.5 Allergan, Inc. (USA) Recent Developments
9.14 Novartis AG (Switzerland)
9.14.1 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Basic Information
9.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Overview
9.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Market Performance
9.14.4 Novartis AG (Switzerland) Business Overview
9.14.5 Novartis AG (Switzerland) Recent Developments
9.15 Novo Nordisk A/S (Denmark)
9.15.1 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Basic Information
9.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Overview
9.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Market Performance
9.15.4 Novo Nordisk A/S (Denmark) Business Overview
9.15.5 Novo Nordisk A/S (Denmark) Recent Developments
9.16 Pfizer, Inc. (USA)
9.16.1 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Basic Information
9.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Overview
9.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance
9.16.4 Pfizer, Inc. (USA) Business Overview
9.16.5 Pfizer, Inc. (USA) Recent Developments
9.17 Sanofi S.A (France)
9.17.1 Sanofi S.A (France) Pediatric Drugs and Vaccines Basic Information
9.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Overview
9.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Market Performance
9.17.4 Sanofi S.A (France) Business Overview
9.17.5 Sanofi S.A (France) Recent Developments
9.18 Shionogi Inc. (USA)
9.18.1 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Basic Information
9.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Overview
9.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance
9.18.4 Shionogi Inc. (USA) Business Overview
9.18.5 Shionogi Inc. (USA) Recent Developments
9.19 Takeda
9.19.1 Takeda Pediatric Drugs and Vaccines Basic Information
9.19.2 Takeda Pediatric Drugs and Vaccines Product Overview
9.19.3 Takeda Pediatric Drugs and Vaccines Product Market Performance
9.19.4 Takeda Business Overview
9.19.5 Takeda Recent Developments
10 Pediatric Drugs and Vaccines Market Forecast by Region
10.1 Global Pediatric Drugs and Vaccines Market Size Forecast
10.2 Global Pediatric Drugs and Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pediatric Drugs and Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Pediatric Drugs and Vaccines Market Size Forecast by Region
10.2.4 South America Pediatric Drugs and Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pediatric Drugs and Vaccines by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Pediatric Drugs and Vaccines Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Type (2024-2029)
11.1.2 Global Pediatric Drugs and Vaccines Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Pediatric Drugs and Vaccines by Type (2024-2029)
11.2 Global Pediatric Drugs and Vaccines Market Forecast by Application (2024-2029)
11.2.1 Global Pediatric Drugs and Vaccines Sales (K MT) Forecast by Application
11.2.2 Global Pediatric Drugs and Vaccines Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings